abstract |
The present invention relates to a method of treating erosive multiple arthritis comprising administering a TNFa antibody, or antigen binding site thereof. The present invention also relates to a method of testing the efficacy of a TNFa antibody or antigen binding site thereof to treat erosive multiple arthritis. |